Product Surveillance Registry (PSR)
Diseases of the Cardiovascular System
What is the purpose of this trial?
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
- Trial withMedtronic, Inc
- Start Date05/08/2013
- End Date02/28/2018
- Last Updated02/22/2018
- Study HIC#1303011669REG